Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: TPL BK: TPL PLAN OF REORGANIZATION 1-20-14
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I agree. What real incentive does the Leckrone family have in licensing the MMP under this plan when they can keep more from their other portfolios.

Leckrone's projection for 100% of his MMP revenues plus 12% of AGR is only $4,483,000 for all of 2014 and around $48million through 2020. That pretty much covers most of the look back period after the expiration of the patents.

Am I looking at this correctly? If so, how much will Patriot receive over this period of time? How much more could Patriot receive if they break the PDS contract and begin licensing on their own?

13 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply